Clinical Trial Services Market
完整報告名稱與涵蓋範圍
Clinical Trial Services Market Size, Share & Trends Analysis Report By Service (Clinical Trial Site Management, Patient Recruitment Management, (Patient recruitment & registry services, Patient retention, Others), Data Management, Administrative staff, IRB, Others), By Phase, (Phase I, Phase II, Phase III, Phase IV), By Sponsor, By Region, Forecasts, 2024-2031
報告摘要
The Clinical Trial Services Market on a global scale was estimated at USD 22.58 billion in 2023 and is poised to attain USD 42.86 billion by 2031, with a projected CAGR of 8.44% between 2024 and 2031.
At its core, Clinical Trial Services pertains to The services used by biopharmaceutical or pharmaceutical companies to conduct clinical trial either for the approval of a new drug or biologic or for the entry of new generic or biosimilar to the mark. Stakeholders across the healthcare landscape are escalatingly turning to these solutions to meet contemporary demands.
Several factors contribute to this trajectory, including heightened interest in next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region poised to deliver the strongest growth trajectory through the forecast period, supported by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Clinical Trial Services Market Snapshot
Chapter 4. Global Clinical Trial Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Service Outlook Estimates & Trend Analysis
5.1. By Service Outlook & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Service Outlook:
5.2.1. Clinical Trial Site Management
5.2.2. Patient Recruitment Management
5.2.2.1. Patient recruitment & registry services
5.2.2.2. Patient retention
5.2.2.3. Others
5.2.6. Data Management
5.2.7. Administrative staff
5.2.8. IRB
5.2.9. Others
Chapter 6. Market Segmentation 2: By Phase Estimates & Trend Analysis
6.1. By Phase & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Phase:
6.2.1. Phase I
6.2.2. Phase II
6.2.3. Phase III
6.2.4. Phase IV
Chapter 7. Market Segmentation 3: By Sponsor Estimates & Trend Analysis
7.1. By Sponsor & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Sponsor:
7.2.1. Pharmaceutical & Biopharmaceutical
7.2.2. Medical Devices
7.2.3. Others
Chapter 8. Clinical Trial Services Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Service Outlook, 2024- 2031
8.1.2. North America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2024- 2031
8.1.3. North America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Sponsor, 2024- 2031
8.1.4. North America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2024- 2031
8.2. Europe
8.2.1. Europe Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Service Outlook, 2024- 2031
8.2.2. Europe Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2024- 2031
8.2.3. Europe Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Sponsor, 2024- 2031
8.2.4. Europe Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2024- 2031
8.3. Asia Pacific
8.3.1. Asia Pacific Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Service Outlook, 2024- 2031
8.3.2. Asia Pacific Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2024- 2031
8.3.3. Asia-Pacific Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Sponsor, 2024- 2031
8.3.4. Asia Pacific Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2024- 2031
8.4. Latin America
8.4.1. Latin America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Service Outlook, 2024- 2031
8.4.2. Latin America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2024- 2031
8.4.3. Latin America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Sponsor, 2024- 2031
8.4.4. Latin America Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2024- 2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Service Outlook, 2024- 2031
8.5.2. Middle East & Africa Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2024- 2031
8.5.3. Middle East & Africa Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by Sponsor, 2024- 2031
8.5.4. Middle East & Africa Clinical Trial Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2024- 2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. PharmaLex
9.2.2. Emergo UL
9.2.3. Cytel
9.2.4. Health Policy Associate
9.2.5. CD BioSciences
9.2.6. LLX Solutions
9.2.7. SGS
9.2.8. ADM Korea
9.2.9. ClinAsia
9.2.10. BioPoint
9.2.11. Covance, Inc
9.2.12. Charles River Laboratories
9.2.13. Alcura Health
9.2.14. Parexel International
9.2.15. Accovion GmbH
9.2.16. ICON PLC
9.2.17. Chiltern International Limited
9.2.18. inVentiv International Pharma Services
9.2.19. Pharmaceutical Product Development LLC
9.2.20. Pharmnet
9.2.21. IQVIA
9.2.22. Syneos Health
9.2.23. Quotient Bioresearch
9.2.24. WuXi PharmaTech
9.2.25. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們